Physician

Robert Blaine Lehr, M.D.

According to 2025 Medicare claims, Robert Lehr, M.D. (NPI: 1619901634) practices dermatology in the Oklahoma City, OK market, with the plurality of this provider's patient population coming from Oklahoma, OK. This provider's primary affiliated billing organization is THE DERMATOLOGY CLINIC INC (NPI: 1750487880; TIN: 730930272) and primary practice location at 73112-7047. Lehr is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), participating under the MSSP model.

Lehr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,453 traditional Medicare patients, billed 15,232 HCPCS/CPT codes, and received $1,140,340 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 3,470 prescription claims across 1,178 beneficiaries totaling $1,538,692 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). 2023 DME data shows 11 claims. Open Payments data shows 102 records totaling $2,139. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $343,990 to $1,140,340. Similarly, Part D prescription costs have moved sharply higher in recent years, from $245,562 to $1,538,692. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,837	10,235	$343,990
2016	1,848	10,692	$353,750
2017	1,786	9,297	$324,214
2018	1,773	9,844	$340,961
2019	1,880	11,039	$468,846
2020	1,624	12,761	$779,784
2021	1,800	15,253	$1,003,037
2022	1,825	16,039	$1,053,621
2023	1,546	16,144	$1,204,299
2024	1,453	15,232	$1,140,340

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	733	2,256	$245,562
2016	731	2,196	$259,095
2017	765	2,272	$288,706
2018	821	2,386	$413,822
2019	907	2,773	$671,685
2020	867	2,665	$642,606
2021	847	2,556	$1,023,677
2022	914	2,679	$1,036,264
2023	936	2,716	$1,080,913
2024	1,178	3,470	$1,538,692

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$512
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	364	431	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	590	822	$58
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	339	398	$36
17000	Destruction of precancer skin growth, 1 growth	523	710	$33
17003	Destruction of precancer skin growth, 2-14 growths	380	2,458	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	15	1,148	$307,828
Dupixent Pen	Dupilumab	59	1,764	$247,902
Odomzo	Sonidegib Phosphate	12	360	$188,851
Dupixent Syringe	Dupilumab	47	1,344	$188,429
Humira(Cf) Pen	Adalimumab	14	392	$94,978

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	102	$2,139	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Blaine Lehr, M.D.?

Tedicare shows public-source Medicare data for Robert Blaine Lehr, M.D. (NPI 1619901634), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Blaine Lehr, M.D. have ACO affiliation data?

Robert Blaine Lehr, M.D. is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616).

What billing organization is linked to Robert Blaine Lehr, M.D.?

Robert Blaine Lehr, M.D. is linked to THE DERMATOLOGY CLINIC INC (billing NPI 1750487880) in the available physician profile data.

Does Robert Blaine Lehr, M.D. have Open Payments data?

Robert Blaine Lehr, M.D. has 102 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.